/Companies

Baseline Therapeutics

2 known investors

Find your way into Baseline Therapeutics

Sign up to see every warm intro you have to Baseline Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Baseline Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.

Investors · 2

Frequently asked questions

What does Baseline Therapeutics do?
Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.
Who are Baseline Therapeutics's investors?
Baseline Therapeutics's investors include Very Serious Ventures, Versant Ventures.